Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2005 Sep;81(959):594–598. doi: 10.1136/pgmj.2004.031690

Comparative study of enema retention and preference in ulcerative colitis

J Ingram 1, J Rhodes 1, B Evans 1, R Newcombe 1, G Thomas 1
PMCID: PMC1743341  PMID: 16143691

Abstract

Background: Therapeutic enemas are often used to treat active colitis but their retention may be limited because of urgency to defecate. Some preparations may be better retained and tolerated than others because of their physical properties.

Aim: To compare patient preference and retention of four therapeutic enemas, including a nicotine enema, in patients with ulcerative colitis (UC).

Methods: Twenty four patients with active UC received the four trial enemas—corticosteroid, 5-amino salicylate (5-ASA), and nicotine liquid enemas and a corticosteroid foam, in a randomised order, taking one enema on each of four successive nights. Patients scored them 1 to 4 for ease of administration and retention, degree of abdominal bloating, and for their overall preference.

Results: Fifteen patients rated nicotine their overall favourite or second favourite, compared with 14 for corticosteroid foam and 11 for 5-ASA and corticosteroid liquids, but this was not significant (p = 0.302). Overall, there was no significant difference in overnight retention. However, the nicotine enema tended to be less well retained in patients with milder urgency but a higher proportion retained it overnight with more severe urgency (p = 0.031 compared with 5-ASA enema).

Conclusion: There was no significant difference in patient preference or overall duration of retention for the four enemas.

Full Text

The Full Text of this article is available as a PDF (64.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campieri M., Lanfranchi G. A., Bazzocchi G., Brignola C., Sarti F., Franzin G., Battocchia A., Labo G., Dal Monte P. R. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet. 1981 Aug 8;2(8241):270–271. doi: 10.1016/s0140-6736(81)90523-7. [DOI] [PubMed] [Google Scholar]
  2. Campieri M., Paoluzi P., D'Albasio G., Brunetti G., Pera A., Barbara L. Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema. Dig Dis Sci. 1993 Oct;38(10):1843–1850. doi: 10.1007/BF01296108. [DOI] [PubMed] [Google Scholar]
  3. Gionchetti P., Ardizzone S., Benvenuti M. E., Bianchi Porro G., Biasco G., Cesari P., D'albasio G., De Franchis R., Monteleone G., Pallone F. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial. Aliment Pharmacol Ther. 1999 Mar;13(3):381–388. doi: 10.1046/j.1365-2036.1999.00482.x. [DOI] [PubMed] [Google Scholar]
  4. Green J. T., McKirdy H. C., Rhodes J., Thomas G. A., Evans B. K. Intra-luminal nicotine reduces smooth muscle tone and contractile activity in the distal large bowel. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1299–1304. doi: 10.1097/00042737-199911000-00020. [DOI] [PubMed] [Google Scholar]
  5. Green J. T., Rhodes J., Thomas G. A., Evans B. K., Feyerabend C., Russell M. A., Sandborn W. J. Nicotine carbomer enemas--pharmacokinetics of a revised formulation. Ital J Gastroenterol Hepatol. 1998 Jun;30(3):260–265. [PubMed] [Google Scholar]
  6. Green J. T., Richardson C., Marshall R. W., Rhodes J., McKirdy H. C., Thomas G. A., Williams G. T. Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther. 2000 Nov;14(11):1429–1434. doi: 10.1046/j.1365-2036.2000.00847.x. [DOI] [PubMed] [Google Scholar]
  7. Green J. T., Thomas G. A., Rhodes J., Evans B. K., Russell M. A., Feyerabend C., Fuller G. S., Newcombe R. G., Sandborn W. J. Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis. Clin Pharmacol Ther. 1997 Mar;61(3):340–348. doi: 10.1016/S0009-9236(97)90167-3. [DOI] [PubMed] [Google Scholar]
  8. Green J. T., Thomas G. A., Rhodes J., Williams G. T., Evans B. K., Russell M. A., Feyerabend C., Rhodes P., Sandborn W. J. Nicotine enemas for active ulcerative colitis--a pilot study. Aliment Pharmacol Ther. 1997 Oct;11(5):859–863. doi: 10.1046/j.1365-2036.1997.00220.x. [DOI] [PubMed] [Google Scholar]
  9. Lee F. I., Jewell D. P., Mani V., Keighley M. R., Kingston R. D., Record C. O., Grace R. H., Daniels S., Patterson J., Smith K. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Gut. 1996 Feb;38(2):229–233. doi: 10.1136/gut.38.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Marshall J. K., Irvine E. J. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut. 1997 Jun;40(6):775–781. doi: 10.1136/gut.40.6.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McKirdy H. C., Richardson C. E., Green J. T., Rhodes J., Williams G. T., Marshall R. W. Differential effect of nitric oxide synthase inhibition on sigmoid colon longitudinal and circular muscle responses to nicotine and nerve stimulation in vitro. Br J Surg. 2004 Feb;91(2):229–234. doi: 10.1002/bjs.4395. [DOI] [PubMed] [Google Scholar]
  12. Moran J., Addy M., Jackson R., Newcombe R. G. Comparative effects of quaternary ammonium mouthrinses on 4-day plaque regrowth. J Clin Periodontol. 2000 Jan;27(1):37–40. doi: 10.1034/j.1600-051x.2000.027001037.x. [DOI] [PubMed] [Google Scholar]
  13. Mulder C. J., Tytgat G. N. Review article: topical corticosteroids in inflammatory bowel disease. Aliment Pharmacol Ther. 1993 Apr;7(2):125–130. doi: 10.1111/j.1365-2036.1993.tb00080.x. [DOI] [PubMed] [Google Scholar]
  14. Ruddell W. S., Dickinson R. J., Dixon M. F., Axon A. T. Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut. 1980 Oct;21(10):885–889. doi: 10.1136/gut.21.10.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sutherland L. R., Martin F., Greer S., Robinson M., Greenberger N., Saibil F., Martin T., Sparr J., Prokipchuk E., Borgen L. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987 Jun;92(6):1894–1898. doi: 10.1016/0016-5085(87)90621-4. [DOI] [PubMed] [Google Scholar]
  16. TRUELOVE S. C. Treatment of ulcerative colitis with local hydrocortisone. Br Med J. 1956 Dec 1;2(5004):1267–1272. doi: 10.1136/bmj.2.5004.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES